Novartis AG
METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR - EXPRESSING CELLS
Last updated:
Abstract:
The invention provides methods of making immune effector cells (e.g., T cells, NK cells) that can be engineered to express a chimeric antigen receptor (CAR), and compositions and reaction mixtures comprising the same.
Status:
Application
Type:
Utility
Filling date:
4 Mar 2019
Issue date:
26 Sep 2019